SNPS AI Stock Analysis – Buy, Hold, or Avoid?
Synopsys, Inc. (SNPS)
Fundamentals
Synopsys (SNPS) demonstrates long-term robust revenue growth and expanding gross profit, but has faced considerable earnings and margin volatility in recent quarters. The company's high valuation multiples reflect significant growth expectations, even as profitability has come under pressure recently. Overall, Synopsys maintains a strong market position, but current elevated risks warrant a cautious near- to medium-term stance.
Financial Highlights
- Revenue
- Net Income
- Net Margin (%)
Revenue
41.87% YoY
Q1 2026
Net Income
-95.05% YoY
Q1 2026
Net Margin
Q1 2026
Growth Metrics
Revenue Growth YoY
Latest Quarter: Q1 2026
Net Income Growth YoY
Latest Quarter: Q1 2026
Revenue Per Share Growth YoY
Latest Quarter: Q1 2026
EPS Growth YoY
Latest Quarter: Q1 2026
Book Value Per Share Growth YoY
Latest Quarter: Q1 2026
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.3B | 2.4B | 2.3B | 1.7B | 1.6B | 1.5B | 1.6B | 1.5B |
| Revenue Growth YoY | +41.87% | +65.52% | +37.83% | +14.03% | +10.28% | -3.68% | +2.30% | +12.65% |
| Net Income | 17.1M | 64.7M | 448.7M | 242.5M | 345.3M | 295.7M | 1.1B | 408.1M |
| Net Income Growth YoY | -95.05% | -78.11% | -59.73% | -40.57% | +18.22% | -34.16% | +219.05% | +21.35% |
| EPS | $0.09 | $0.40 | $2.42 | $1.51 | $2.25 | $1.91 | $7.24 | $2.66 |
| EPS Growth YoY | -96.00% | -79.06% | -66.57% | -43.23% | +17.80% | -35.25% | +214.78% | +20.36% |
Profitability Metrics
Technical Analysis
SNPS is currently in a bearish downtrend trading below key moving averages, with technical indicators signaling a developing but weak downward momentum. Support levels near $451-$454 hold short-term interest, while resistance zones between $470-$480 are proving significant hurdles. Chart patterns and MACD signals remain mixed, reflecting uncertainty with a prevailing negative bias.
Earnings
Synopsys (SNPS) demonstrates long-term robust revenue growth and expanding gross profit, but has faced considerable earnings and margin volatility in recent quarters. The company's high valuation multiples reflect significant growth expectations, even as profitability has come under pressure recently. Overall, Synopsys maintains a strong market position, but current elevated risks warrant a cautious near- to medium-term stance.
Valuation
Synopsys (SNPS) currently trades at elevated valuation multiples well above industry averages, reflecting strong revenue growth but compressed earnings and cautious investor sentiment. Analysts generally maintain a positive outlook with a consensus buy/hold stance and an average price target suggesting significant upside potential. However, technical indicators reveal near-term weakness and mixed signals, indicating market uncertainty.
Valuation Metrics
Price to Earnings
TTM
Price to Sales
TTM
Price to Book
TTM
Enterprise Value to EBITDA
TTM
Enterprise Value to Revenue
TTM
| Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | |
|---|---|---|---|---|---|---|---|---|
| Price to Earnings | 1340.56 | 290.70 | 46.88 | 104.88 | 51.00 | 68.78 | 17.74 | 52.47 |
| Price to Sales | 40.40 | 30.93 | 32.24 | 58.32 | 44.33 | 55.75 | 48.32 | 56.14 |
| Price to Book | 3.02 | 2.44 | 2.57 | 3.67 | 7.17 | 8.72 | 8.79 | 11.11 |
| Enterprise Value to EBITDA | 164.78 | 169.87 | 72.47 | 253.35 | 125.57 | 223.45 | 167.22 | 183.67 |
| Enterprise Value to Revenue | 44.10 | 34.56 | 37.30 | 65.57 | 42.22 | 53.70 | 46.36 | 55.38 |
Sentiment & Analyst Ratings
Synopsys (SNPS) exhibits a generally positive market sentiment supported by a majority of analyst "Buy" ratings with compelling price targets suggesting 20%+ upside potential. The company has recently reported strong earnings beats and raised its fiscal outlook driven by AI-related demand and synergies from the Ansys acquisition. However, elevated valuation metrics and insider selling introduce a cautious undertone, leading to a somewhat mixed sentiment picture from investors and analysts alike.
Analyst Recommendations
No analyst recommendations available.
Risk Assessment
Synopsys presents a moderate financial risk profile supported by solid liquidity and manageable debt levels. The company faces external risks such as geopolitical uncertainty, industry competition, and challenges integrating recent acquisitions, which may pressure performance despite a strong market position. Overall, investors should weigh these structural risks against fundamental strengths and growth potential.
Liquidity & Solvency
Frequently Asked Questions about SNPS
AI Answers: Common Questions About SNPS
Get AI-powered answers to the questions investors ask most about Synopsys, Inc.
SNPS is not an ideal buy right now for short-term traders due to bearish technicals and a high P/E ratio of 104.7x, with price trading below all major moving averages. However, long-term investors may consider accumulating on further weakness, as analyst price targets average $550-$675 and the company remains a market leader in a growth industry.
If you are a short-term trader or risk-averse, consider reducing exposure as technicals are bearish and earnings have deteriorated sharply (EPS down 75% sequentially). Long-term holders can maintain positions but should monitor for further margin declines or failed acquisition integration.
The biggest risks are margin compression (operating margin dropped from 22% to 10%), integration challenges with the Ansys acquisition (debt-to-equity ~0.36, interest coverage 1.7x), and potential valuation derating if earnings do not recover. Macroeconomic and regulatory risks also persist.
Technical resistance is at $470-$480, with strong support at $451-$454 and downside risk to $446. Analyst targets cluster in the $550-$675 range, implying 20-40% upside if fundamentals stabilize, but near-term price action is weak.
SNPS is overvalued by most metrics: P/E is 104.7x, P/S near 10x, and EV/EBITDA ~35x, all well above sector averages and its own history. This premium reflects high growth expectations, but recent earnings weakness makes these multiples vulnerable.
Fundamentally, Synopsys is strong in terms of revenue growth (~15% FY25, 42% YoY Q1 2026) and recurring revenues, but recent quarters saw gross margin contract from 81% to 72% and operating margin fall to 10%. The balance sheet is solid with a current ratio of 1.43 and debt-to-equity of 0.36.
Technically, SNPS is in a bearish downtrend: price is below the 50, 150, and 200 SMAs, RSI is 41 and trending lower, and MACD is negative. Support is at $451-$454, resistance at $470-$480, and there are no strong reversal signals yet.
Key catalysts include upcoming earnings (for margin recovery), progress on Ansys integration, and new AI-driven product launches. Macro events affecting semiconductor demand and regulatory developments are also important to watch.
Want a Personalized Answer?
Get AI-powered insights tailored to your risk tolerance and investment goals.